Breaking News

Prevalence of cardiometabolic abnormalities in individuals with moderate-severe plaque psoriasis

Prevalence of cardiometabolic abnormalities in individuals with moderate-severe plaque psoriasis

 
 

The multinational PRISTINE study assessed the efficacy and safety of two different regimens of etanercept in 273 patients with moderate-severe plaque psoriasis. Baseline cardiometabolic parameters for this group were presented. The prevalence of various parameters were as follows: hypertension (36%), metabolic syndrome (39%), diabetes mellitus (14%) and prediabetes (34%). Of the diabetic and prediabetic patients, 31 and 17% had evidence of chronic renal disease, respectively (Puig, L. et al. 40th Meeting Eur Soc Dermatol Res [Sept 8-11, Helsinki] 2010, Abst 408).

 
to Continue Reading, Login Now
 

Please Login

 
 
  
 
 
If you are a registered user but you have forgotten your password, please click here
 
If you are not a registered user, please register here

return to breaking news list